Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,153.00
Market cap
₹1,16,019 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.7×Sector 47.3×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:08 IST NSE
Management Change

Zydus Lifesciences Management Change

Zydus Lifesciences shareholders approved the re-appointment of Dr. Sharvil P. Patel as Managing Director and the appointment of Mr. Kulin S. Lalbhai as an Independent Director.

14:15 IST NSE
Management Change

Zydus Lifesciences Management Change

Zydus Lifesciences re-appointed Dr. Sharvil P. Patel as Managing Director and appointed Mr. Kulin S. Lalbhai as Independent Director. Both roles carry five-year terms.

Execution
5 years
10:14 IST NSE
Management Change

Zydus Lifesciences Management Change

Mr. Apurva S. Diwanji ceased to be an Independent Director at Zydus Lifesciences following his tenure completion. The change was effective from May 12, 2026.